What this means

ABCA4 is a retinal protein that clears toxic byproducts of the visual cycle. Loss-of-function variants cause Stargardt disease, an inherited cause of central vision loss. G1961E is one of the more common ABCA4 variants in some populations and is generally associated with milder, later-onset disease compared with truncating variants. Two-copy carriers benefit from ophthalmologic follow-up and vision-preservation strategies.

ABCA4 is a protein in the retina at the back of your eye that clears away toxic by-products produced when you see. When ABCA4 doesn't work properly, those by-products build up and damage the cells that handle central vision — this is called Stargardt disease. The G1961E change is one of the more common ABCA4 problems in some groups and tends to produce a milder, later-onset form than the more severe ABCA4 changes. People with two copies benefit from regular eye specialist visits and steps to protect remaining vision.

Caveats

• One copy is carrier status — usually no clinical impact.
• Many ABCA4 variants exist; a single SNP is an incomplete view of Stargardt risk.
• Two-copy results warrant clinical confirmation and ophthalmology referral.

References

• Allikmets et al. — A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy (Nature Genetics, 1997)
• Lewis et al. — Genotype/Phenotype analysis of a photoreceptor-specific ATP-binding cassette transporter gene, ABCR, in Stargardt disease (AJHG, 1999)